Van Hulzen Asset Management LLC Buys 1,551 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Van Hulzen Asset Management LLC lifted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 5.4% in the 2nd quarter, Holdings Channel reports. The fund owned 30,175 shares of the company’s stock after acquiring an additional 1,551 shares during the quarter. Van Hulzen Asset Management LLC’s holdings in Addus HomeCare were worth $3,504,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Texas Permanent School Fund Corp raised its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after purchasing an additional 82 shares during the period. Choreo LLC acquired a new position in Addus HomeCare during the 2nd quarter worth approximately $340,000. Wedbush Securities Inc. grew its stake in shares of Addus HomeCare by 9.6% during the 2nd quarter. Wedbush Securities Inc. now owns 3,305 shares of the company’s stock worth $384,000 after acquiring an additional 290 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at approximately $31,000. Finally, Arizona State Retirement System lifted its position in shares of Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after purchasing an additional 87 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Up 0.4 %

ADUS opened at $126.85 on Tuesday. Addus HomeCare Co. has a 12-month low of $78.35 and a 12-month high of $134.78. The business has a 50 day moving average of $124.86 and a 200-day moving average of $111.91. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of 31.48, a PEG ratio of 2.31 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 earnings per share. As a group, analysts expect that Addus HomeCare Co. will post 4.53 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on ADUS. Macquarie started coverage on shares of Addus HomeCare in a research report on Friday, June 28th. They issued an “outperform” rating and a $136.00 target price for the company. Royal Bank of Canada restated an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. TD Cowen upped their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Finally, Oppenheimer upped their price objective on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $127.57.

Read Our Latest Stock Analysis on ADUS

Insider Activity at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,634 shares of company stock worth $3,011,532. Insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.